Inhibrx Biosciences, Inc. INBX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s pre-tax income?
- Inhibrx Biosciences, Inc. (INBX) reported pre-tax income of -$33.44M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s pre-tax income changed year-over-year?
- Inhibrx Biosciences, Inc.'s pre-tax income increased by 22.8% year-over-year, from -$43.31M to -$33.44M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s pre-tax income?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s pre-tax income has grown at a -23.6% compound annual growth rate (CAGR), from -$239.72M to -$140.05M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.